Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This issue contains notes by Dr. Bradley Wolf and mentions comments by Dr. Jerry Cooley, but it presents no new research findings.

This review discusses telogen effluvium, a common form of hair loss, and reports no new clinical results; the authors outline possible causes, typical prognosis, and management strategies.

In a cross-sectional analysis of 58 hair growth cosmeceuticals marketed for women or unisex use, this study found that ingredients with potential environmental hazards, particularly phenoxyethanol and synthetic fragrances, are commonly present, while substances like sodium lauryl sulfate, parabens, and microbeads were not detected.

This study found that dermatologists in the southeastern U.S. often offer less frequent treatment for children with alopecia areata compared to adults, with more treatment also recommended for more advanced stages of hair loss.

This abstract explains that androgenetic alopecia, a common hair loss disorder influenced by genetics and hormones like dihydrotestosterone, has FDA-approved treatments including minoxidil, finasteride, and photolaser therapy, but its genetic basis and susceptibility to environmental factors remain complex.